- Oops!Something went wrong.Please try again later.
The FDA has raised concerns about one of the company's key pipeline candidates in advance of a crucial meeting.
(Bloomberg) -- Jeremy Grantham got the market’s attention with his “super bubble” call on U.S. stocks. Now he wants to get an even more alarming and urgent message out, one his critics may find harder to accept. Most Read from BloombergStock Rebound Fails and Futures Plunge on Earnings: Markets WrapMark Zuckerberg’s Stablecoin Ambitions Unravel With Diem Sale TalksNvidia Quietly Prepares to Abandon $40 Billion Arm BidA Nor’easter Approaching New York Risks Becoming a Bomb CycloneStocks Storm Bac
Markets have reeled since the Federal Reserve announced, through the release of the December minutes, that the central bank would like to take a big whack at its $9 trillion balance sheet rather than keep it at that lofty level. Value stocks, they argue, will continue to be boosted by the transition from quantitative easing to quantitative tightening, as the Fed pivots from fighting deflation to fighting inflation. By and large, the Goldman team says most of the moves in the market have been explained by fundamentals, but it says some defensive sectors, including food and beverages, household goods and personal products, may have rerated too much, while semiconductors may have sold off by too much.
Yahoo Finance Live's Julie Hyman and Brian Sozzi discuss fourth quarter earnings for Boeing and how the stock is reacting.
Technology stocks have continued to see heavy selling activity in 2022. Cathie Wood has been buying the dip in three names in particular.
Elon Musk has been driving Telsa's new Cybertruck and he thinks it's 'awesome.' An electric truck opens a substantial new market for Tesla.
Peloton (NASDAQ: PTON) stock is in a world of hurt in recent months. The interactive exercise equipment maker initially cut the price of one of its popular products by $400 and is now reversing course and increasing prices. Only a couple of quarters ago, Peloton announced it would be reducing the price of its Bikes by $400.
Every investor in Alibaba Group Holding Limited ( NYSE:BABA ) should be aware of the most powerful shareholder groups...
The central bank, which has held short-term interest rates at near-zero since March 2020, is not anticipated to raise interest rates at the conclusion of Wednesday's meeting.
On yet another "red" day for stock markets, marijuana investors saw their stocks tumble right along with the rest of the Nasdaq. In a press release early this morning, Hexo gave investors an update on its strategic plan entitled "The Path Forward," explaining how Hexo -- shares of which traded above $30 just a couple of years ago, but now fetch just $0.50 -- intends to regain its mojo and get its share price moving higher once again. New product launches appear key to Hexo's plan, as the company launches sales of a "transdermal cream and a CBD-forward body lotion," and also a new line of "gummy confection called Redebles."
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett is one of the world's greatest investors. Between Dec. 31, 1964 and Dec. 31, 2021, he oversaw the creation of more than $600 billion in market value and led Berkshire's Class A shares (BRK.A) to aggregate gains in excess of 3,600,000%! Of the more than three-dozen securities Berkshire Hathaway owns in its $350 billion investment portfolio, three stand out as wholly avoidable in 2022.
Yahoo Finance Live's Emily McCormick and Adam Shapiro break down several of the trending stocks attempting to correct themselves during this volatile trading week.
Boeing's Q4 results fell short of expectations as it saw charges on its 787 Dreamliner and KC-46 programs. Boeing stock fell early Wednesday.
After a promising start, General Electric (NYSE: GE) spent most of the last year in sideways movement as the reverse stock split in August and the announced 3-way breakup of the company in November did little to improve the sentiment. Yet, as uncertainty about the overall market grows, turnaround stories like GE bring on increased risks. View our latest analysis for General Electric
Yahoo Finance's Jared Blikre examines Microsoft's after-hours trading. Greg Swenson, Brigg Macadam Founding Partner, and John Kicklighter, DailyFX Chief Strategist, provide additional commentary on Microsoft's earnings during a volatile market.
Clorox (NYSE: CLX) is one dividend-paying company that thrived at the pandemic onset as folks urgently looked for disinfectant products. The rest of Clorox's product portfolio also performed well as most of them are used at home, and people have been spending a lot more time there. In the beginning of Clorox's fiscal year 2022, sales are decreasing slightly as the fear of contracting COVID-19 diminishes.
Former President Donald Trump is starting a social media network and streaming service called Truth Social and TMTG+, respectively, taking the companies public under Trump Media & Technology Group in a SPAC merger with Digital World Acquisition (NASDAQ: DWAC). Trump's headbutting with large media companies has been well-publicized, including his banishment from social media platforms like Twitter and Facebook (owned by Meta Platforms).
Yahoo Finance's Jennifer Schonberger joins the Live show to discuss the White House's plans to release a National Security Council memorandum that will regulate cryptocurrencies as soon as early February.
Shares of SmileDirectClub (NASDAQ: SDC) surged higher on Tuesday, soaring as much as 25.1%. The catalyst that drove the oral healthcare company higher was a strategic shift to cut costs and focus on its most profitable markets. SmileDirectClub announced that it was taking a number of "strategic actions" to position the company for future growth while improving its business performance.
The U.S. equity market has been quite volatile in January 2022. Rising omicron cases, sticky inflation, which is expected to result in rate hikes, and now weaker-than-anticipated earnings results for tech stocks have negatively affected investor sentiment. Qualcomm (NASDAQ: QCOM) and Pfizer (NYSE: PFE) are two such picks that have the potential to provide solid returns for retail investors in the long run.
Shares of the maker of a leading Covid-19 at-home antigen test were down slightly in premarket trading Wednesday.